PRKN and neoplasm: While we agree that in some cancers parkin may be a tumor suppressor [5], we find elevated endogenous levels of parkin in antiestrogen resistant LCC9 breast cancer cell lines when compared with their endocrine sensitive parental control cells (LCC1; Figure 2).